Based on Research by Burr et al., September 2021
Introduction
The 2021 study by Burr, Cheung, and colleagues provides an evidence-based review of cannabis use among athletes. The paper evaluates its effects on performance, recovery, and health, emphasizing the balance between potential therapeutic applications and adverse outcomes.
Key Findings
- Performance Impairments: Cannabis negatively affects motor control, coordination, and reaction times, offering no measurable benefit for physical performance. Cognitive and psychomotor impairment may persist for hours, raising safety concerns during training or competition.
- Potential Therapeutic Uses: Limited evidence suggests cannabis may reduce pain and inflammation, offering subjective benefits for recovery. However, these effects are inconsistent, and high THC concentrations might delay tissue healing or impair sleep quality.
- Adverse Effects: Cannabis use is associated with tachycardia, altered blood pressure, and potential cognitive deficits, presenting risks for cardiovascular and neurological health.
- Regulatory Considerations: Cannabis remains a prohibited substance in many sports. Providers should counsel athletes on its legal and ethical implications, especially as detection thresholds and tolerance policies evolve.
The VitalPoint for Providers
Cannabis has no established role in enhancing athletic performance and presents risks that may outweigh potential therapeutic benefits. Providers should educate athletes about evidence-based alternatives for pain management and recovery while considering individual needs, legal constraints, and sport-specific regulations.
Further Reading:
- Original Research on Cannabis and Athletics
- American College of Sports Medicine Position on Cannabis